IONQ

Executive Summary

IonQ: Quantum Computing's Revenue Leader Faces Valuation Reckoning

IonQ is the first pure-play quantum computing company to surpass $100M in annual revenue, posting $130M in FY2025 (up 202% YoY) and a record $64.7M in Q1 FY2026 (up 755% YoY). The company has raised its FY2026 revenue guidance to $260–$270M, implying roughly 100%+ organic growth. With a $470M RPO backlog (up 554% YoY) and $3.1B in cash and investments, IonQ has both the demand pipeline and financial runway to execute its ambitious roadmap through the decade.

Technologically, IonQ achieved a world-record 99.99% two-qubit gate fidelity and launched the AQ 64 Tempo system. The company is targeting a 256-qubit system by late 2026 and plans to offer commercially available interconnected quantum systems by 2028. Strategic acquisitions of Oxford Ionics and partnerships with AstraZeneca, AWS, and NVIDIA on drug discovery workflows demonstrate real-world commercial traction beyond research contracts.

However, the investment case carries significant risks. Gross margins compressed to 23.8% in Q1 FY2026 from 40.4% in FY2025 as hardware system sales (lower margin) grow as a share of revenue. R&D spending consumed 235% of FY2025 revenue, and adjusted EBITDA losses remain substantial at ~$97M per quarter. At 53.6x forward EV/revenue, the stock prices in near-flawless execution — any technical delays, competitive threats from IBM or Google, or a broader quantum sentiment downturn could trigger sharp corrections.

The risk/reward profile is asymmetric but binary. IonQ is the clear trapped-ion leader with unmatched revenue scale among quantum pure-plays, but profitability remains years away and the valuation leaves minimal margin of safety. Investors must weigh extraordinary top-line momentum against extreme valuation multiples and the inherent uncertainty of quantum computing's commercial timeline.

Fundamentals

Key Metrics & Valuation — Pre-profit quantum computing pure-play with hypergrowth revenue

Revenue Growth (YoY)

755%

Q1 FY2026 vs Q1 FY2025 — full-year FY2025 grew 202% YoY

Gross Margin

23.8%

Q1 FY2026 — down from 40.4% in FY2025 due to hardware mix shift

Adj. EBITDA Loss

($96.8M)

Q1 FY2026 — deeply negative as R&D outpaces revenue at pre-profit stage

Cash & Investments

$3.1B

As of March 31, 2026 — $493M cash + $2.6B investments

EV / Revenue (Forward)

53.6x

Based on ~$265M FY2026 revenue guidance midpoint

R&D % of Revenue

235%

FY2025: $305.7M R&D on $130M revenue — heavy investment phase

Remaining Performance Obligations

$470M

Up 554% YoY as of Q1 FY2026 — record backlog

Quarterly Cash Burn (Adj.)

~$97M

Q1 FY2026 Adj. EBITDA loss — ~31 quarters of runway at current rate

Quarterly Revenue Trajectory

$20.7M

Q2'25

$39.9M

Q3'25

$61.9M

Q4'25

$64.7M

Q1'26

Quantum Computing

Trapped-Ion Technology Leader Scaling Revenue at Hypergrowth Rates

755%

Q1 FY2026 Revenue Growth

$64.7M vs $7.6M in Q1 FY2025

$470M

RPO Backlog

Up 554% YoY — record contract pipeline

$3.1B

Total Liquidity

Cash, equivalents & investments as of March 2026

Q2 2026

Q2 FY2026 Earnings

Revenue guided $65–$68M. Beat/miss will validate raised full-year $260–$270M outlook.

H2 2026

256-Qubit System Launch

Targeted for late 2026. Delivery would represent a major competitive milestone in trapped-ion quantum computing.

2026

Oxford Ionics Acquisition Close

Definitive agreement signed. Adds complementary trapped-ion IP and manufacturing capabilities for vertical integration.

2026–2027

Government Contract Expansion

IonQ Federal pursuing classified and unclassified U.S. government quantum contracts.

2028

Networked Quantum Systems

IonQ plans commercially available interconnected quantum systems — a potential inflection point for enterprise adoption.

Earnings & Signals

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus-$1.40

FY+2 EPS Consensus-$0.85

PEG Ratio0.55

Forward P/EN/A (pre-profit)

EPS Revisions (90d)↑3 ↓1 (Positive — Q1 FY2026 beat triggered upward revisions)

Guidance AccuracyConsistently beats — raised FY2026 guidance from $225–$245M to $260–$270M after Q1 beat

Earnings Surprise Track Record

Q2 FY2025 Est: -$0.30 Act: -$0.70 -133%

Q3 FY2025 Est: -$0.36 Act: -$0.17 +53%

Q4 FY2025 Est: -$0.48 Act: -$0.20 +58%

Q1 FY2026 Est: -$0.52 Act: -$0.34 +35%

Beat Rate75% (3 of last 4 quarters)

Insider Activity (90 Days)

Net Buying/SellingNet Selling

Sell/Buy Ratio14:0 sell (no open-market buys in last 90 days)

Bearish

Peter Chapman sold $37.4M in first discretionary sale shortly after stepping down as CEO. CEO Niccolo de Masi disposed of 20,785 shares for tax purposes in March 2026.

Peer Comparison

Relative Valuation vs. Competitors

Company	EV/Revenue (FWD)	Rev Growth (YoY)	Gross Margin	Market Cap
IonQ	~56x	+755%	23.8%	$23.8B
Rigetti Computing	~870x	+199%	31.3%	$8.6B
D-Wave Quantum	~176x	-81%	82.6%	$10.9B
Quantum Computing Inc.	~179x	+9,385%	N/A	$2.6B

IonQ commands the largest market cap among pure-play quantum stocks and is the only name with positive YTD returns (+16%) in 2026. However, its 23.8% gross margin lags D-Wave's 82.6% SaaS-like margins. All four trade at extreme revenue multiples reflecting speculative growth premiums.

Valuation

Price Targets & Scenarios

Scenario	Price Target	Assumptions	Probability
Quantum Dominance	$110	IonQ delivers 256-qubit system on time in late 2026, wins major government/enterprise contracts, RPO backlog expands past $700M, FY2026 revenue exceeds $280M, and quantum computing TAM narrative accelerates with clear commercial use cases.	20%
Execution on Roadmap	$68	IonQ meets raised FY2026 guidance of $260–$270M revenue, gross margins stabilize near 30%, cash burn remains manageable with $3.1B war chest, 256-qubit system progresses but may slip to early 2027.	45%
Quantum Winter Returns	$28	Technical delays on 256-qubit milestone, IBM/Google superconducting approaches gain ground, enterprise adoption slows, gross margins deteriorate below 20%, RPO conversion disappoints, broader tech sell-off compresses multiples.	35%

Probability-Weighted Target: $62 (-3% from current price)

$62

Weighted

Bull $11020%

Base $6845%

Bear $2835%

Analyst Consensus

Jefferies

$85

Reiterated Buy — sees quantum adoption tailwinds accelerating

Benchmark

$65

Maintained Buy — lowered from $75 on Feb 26, 2026

Northland Capital

$55

Initiated Outperform — April 20, 2026

Craig-Hallum

$65

Reiterated Buy — 'next two years will be crucial'

Strong Buy consensus among 13 analysts. Average price target of $67.64 implies ~6% upside. Range: $35 (Morgan Stanley) to $100 (Jefferies). Revenue beats and raised guidance have sustained bullish sentiment.

Technical

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High

$84.64

Key Resistance

$72.00

Current Price

$63.64

50-Day MA

$52.47

200-Day MA

$46.49

Key Support

$44.68

52-Week Low

$25.89

OptOptions & Sentiment

Implied Volatility: ~104% — IV rank at 85th percentile; options extremely expensive
Put/Call Ratio (OI): 1.22 — moderately bearish skew; hedging activity elevated
Short Interest: 23.6% of float (~83.7M shares) — well above quantum peer average of 9.8%; squeeze potential
Max Pain: ~$50–$55 range — stock trading above max pain
Options Volume: ~191K contracts — calls outpacing puts 2:1; heavy speculative activity
RSI (14-day): 75.8 — overbought territory; stretched above key moving averages
MACD Signal: MACD at 3.94 — histogram fading from 0.83 to 0.41; bullish momentum decelerating

Risk & Ownership

Risk Assessment & Insider Signals

!Risk Factors

Commercialization Timeline Risk: IonQ remains in early-stage commercialization with no proven killer app at scale. Adjusted EBITDA loss guidance of ($330M)–($310M) for FY2026 underscores the gap between revenue growth and profitability.
Dilution & Stock-Based Compensation: SBC hit $128.5M in Q1 2026 alone — nearly 2x quarterly revenue. The company raised $2B via equity offering. Persistent shareholder dilution at 138x P/S.
Big Tech Competition (IBM, Google, Microsoft): Hyperscalers investing tens of billions in quantum with superconducting, topological, and hybrid approaches. Captive customer bases and unlimited R&D budgets threaten IonQ's trapped-ion advantage.
Technology & Error Correction Risk: Scaling to 256+ qubits and achieving fault tolerance remains unproven at commercial scale. Any delay undermines the competitive narrative and revenue trajectory.
Revenue Concentration & Government Dependency: Approximately 40% of Q1 2026 revenue from government channels. Wolfpack Research alleged reliance on cancelled Pentagon earmarks. Loss of key contracts could create material shortfall.
Macro & Sentiment Whiplash: IONQ trades at ~138x P/S with no path to positive FCF. Quantum stocks are highly correlated with speculative sentiment — extreme boom-bust cycles. Short-seller attacks amplify volatility.

OOwnership & Insider Signals

Vanguard Group — 11.70% (29.35M shares): Largest institutional holder. Position reflects broad index inclusion.
Morgan Stanley — 10.50% (26.34M shares): Second-largest holder with active/passive hybrid position.
BlackRock — 8.96% (22.48M shares): Third-largest institutional holder with 5%+ beneficial ownership.
New Enterprise Associates (NEA) — ~14.6M shares: Long-standing venture backer from IonQ's private rounds.
Institutional / Insider / Retail Split: ~64–67% institutional, ~2.5–14% insiders, ~21–30% retail. Wide retail float contributes to elevated volatility.
Christopher Monroe — ~3.9M shares: Co-founder and Chief Scientist. Continued holding signals long-term scientific confidence.

Recommendation

Summary

Rating

HOLD

Conviction

Medium

Price Target

$62

Timeframe

12 mo

Upside

-3%

Position Size

1%-3%

Entry Strategy

Tranche 1 — 40%

~$50

Enter on pullback to 50-day MA ($52) or below. This level has acted as support during the recent rally and offers better risk/reward.

Tranche 2 — 35%

~$45

Add at 200-day MA ($46.49) on broader market weakness or quantum sentiment correction. This is the key structural support level.

Tranche 3 — 25%

~$35

Final tranche near bear-case support ($28–$35 range) on any quantum winter scenario. Only if thesis remains intact on technology roadmap.